We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




Events

17 Jun 2026 - 19 Jun 2026
08 Jul 2026 - 10 Jul 2026

Protein Patterning: Novel Tool for Studying Sepsis

By LabMedica International staff writers
Posted on 18 Jan 2016
In a new approach using quantitative targeted proteomics, researchers have for the first time developed a way to use mass-spectrometry to measure hundreds of organ proteins in a single blood sample. More...
The resulting protein patterns can help determine sepsis severity, which organs have been damaged, and may lead to faster diagnostics.

“We use the blood as a mirror reflecting what happens in the body,” said Johan Malmström biomedical scientist at Lund University (Lund, Sweden), whose brothers, medical intern Erik Malmström (Lund U.) and bioinformatician Lars Malmström University of Zurich (Zurich, Switzerland) are fellow researchers on the study. The team has succeeded to map the majority of all detected proteins from vital organs (e.g., heart, lung, liver, spleen, blood vessels) and have listed which proteins were specific to each organ.

“If you see in a blood sample that the amount of proteins from a specific organ significantly increases, it indicates damage to this organ. The method provides an understanding of the molecular events that take place during the course of a disease, and the possibility, using the same analysis, to study how different organs are affected”, explained Dr. E. Malmström.

Sepsis is a very complicated and precarious condition in which the immune system starts to react erroneously in different ways to the bacterial infection. It is often difficult to diagnose because symptoms (including high breathing rate, fever, rapid pulse, pain, confusion) occur in milder conditions as well. Disease progression can be very fast and become fatal within a few hours. Therefore, there is a great need for faster diagnosis and better understanding of the course of the disease.

Another researcher, Dr. Adam Linder (Lund U.), has begun to develop a diagnostic method based on HBP, a protein emitted from white blood cells and reflects the risk of hypotension. The Malmström group’s study of hundreds of different proteins could eventually be used to select other important proteins that can serve as biomarkers for different aspects of sepsis.

The new method is already an important research tool: “There is so much we don’t know about sepsis. Why do not all patients react the same way—why do some organs suffer the most damage in some patients and not in others? Do different bacteria cause the disease to progress? Can you divide patients into different subgroups, or bacteria, or does each new combination of patients and bacteria lead to a specific form of sepsis?” asked Dr. E. Malmström. The researchers have conducted their studies on animals and are now moving on to human tissue. Through a collaboration with surgeons at Skane University Hospital they have obtained samples of healthy tissue. Protein patterns of these samples can then be compared with the corresponding organ tissues in sepsis patients.

“Protein mapping like this has never been done before. The method can also be applied to other diseases for studying how pathological changes in various organs are reflected in a blood sample,” said Dr. Johan Malmström.

The study, by Malmström E, Kilsgard O, Hauri S, Smeds E, Herwald H, Malmström L, & Malmström J, was published January 6, 2016, in the journal Nature Communications.

Related Links:

Lund University
University of Zurich 



Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
Online QC Software
Acusera 24•7
Automated Clinical Chemistry Analyzer
Envoy 500+
Benchtop Thermomixer
Biometra TS1 ThermoShaker
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Researchers use a novel immobilized liposome-bound gel beads method to measure CEC levels and their association with cardiovascular risks (Photo courtesy of Institute of Science Tokyo)

Simple Blood-Based Cholesterol Efflux Assay Identifies High-Risk Coronary Plaque Features

Unstable coronary plaques are difficult to identify before they trigger acute cardiovascular events. Standard high-density lipoprotein (HDL) measurements do not always capture how well HDL particles function... Read more

Pathology

view channel
Image: Overview of the uncertainty-aware lensfree computational pathology platform for automated HER2 assessment. A compact lensfree holographic imaging system captures diffraction patterns from immunohistochemically stained breast tissue samples, which are computationally reconstructed and analyzed using deep neural networks with Bayesian uncertainty quantification. (Photo courtesy of Ozcan Lab, UCLA)

Uncertainty-Aware AI Platform Supports Automated HER2 Assessment in Breast Cancer

Accurate assessment of human epidermal growth factor receptor 2 (HER2) is critical for breast cancer diagnosis and treatment selection, yet scoring variability and infrastructure requirements can complicate... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.